Cargando…
MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b
The clinical application of doxorubicin (DOX) is limited because of its cardiotoxicity. However, the pathogenic mechanism of DOX and the role of miRNA in DOX-induced cardiotoxicity remain to be further studied. This study aimed to investigate the role of miR-199 in DOX-mediated cardiotoxicity. A mou...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307339/ https://www.ncbi.nlm.nih.gov/pubmed/35873641 http://dx.doi.org/10.1155/2022/4364779 |